2010
DOI: 10.1071/sh09077
|View full text |Cite
|
Sign up to set email alerts
|

Adding to the menu of modern methods - the diaphragm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Cervical caps as a class have a long history as contraceptives (Chalker 1987), though only one model, the FemCape, continues to be available worldwide. Poor promotion of this device, however, as with other cervical barriers (Holmes 2010) has led to low clinician familiarity, negative attitudes and consequent low awareness and demand among women. Presently, the device when ordered individually costs nearly US$90, 1 though the infrequent need for replacement helps to offset this price, especially in relation to the cost of other contraceptive drugs or devices.…”
Section: Introductionmentioning
confidence: 99%
“…Cervical caps as a class have a long history as contraceptives (Chalker 1987), though only one model, the FemCape, continues to be available worldwide. Poor promotion of this device, however, as with other cervical barriers (Holmes 2010) has led to low clinician familiarity, negative attitudes and consequent low awareness and demand among women. Presently, the device when ordered individually costs nearly US$90, 1 though the infrequent need for replacement helps to offset this price, especially in relation to the cost of other contraceptive drugs or devices.…”
Section: Introductionmentioning
confidence: 99%
“…3,16 Despite this clear need for expanded choice in a FP menu, female barrier methods are often not promoted or available in such communities, and there is a documented provider bias based on the concept that women cannot successfully understand or use them. [17][18][19] This continuing health disparity takes on even greater importance because the female condom-a female barrier methodremains to date the only demonstrated highly efficacious, women-initiated option ensuring autonomous protection against sexually transmitted infection (STI)/HIV. The development of future multipurpose prevention technologies (MPTs) 20,21 will surely include female barrier methods as a mainstay; two recent trials confirmed a female-inserted, tenofovir-loaded vaginal ring to be effective in reducing risk of HIV, and development is underway for the ring to combine both contraceptive with disease-reducing properties.…”
mentioning
confidence: 99%